OK OK, enough of the personal jabs guys.
Changing topic, I'd really like to get an update on Sara Alicia and how that is progressing. In my view that should be the company's short term focus as I feel it brings the most immediate value to the table, what are people's thoughts on it vs Alacran / Opposura?